Background: Drugs are essential to cure diseases and it is crucial to maintain the safety and stability of drugs during the supply chain process. Therefore, the Korean government manages drug distribution in accordance with the Pharmaceutical Affairs Act, even if the efficacy of drugs is guaranteed through manufacturing. The drug wholesale distribution market continues to grow and the types of wholesalers are diversifying. This study aims to identify issues related to drug distribution and to draw improvement measures. Methods: In order to explore a plurality of perspectives, data were obtained from five focus groups composed of employees from pharmaceutical companies, wholesalers, hospitals, pharmacies, and public health center. A semi-structured guide was applied in obtaining the participants’ opinions. Common themes were extracted by authors, which were used to gather results and draw conclusion. Results: Participants acknowledged that as the number of wholesale transactions increases, the drug supply chain becomes complicated, making it difficult to check the transparent distribution flow. Participants concerned about low barrier to market entry by wholesalers, soft regulation of distribution management, and conflict of interest among players in drug market. Conclusions: This study suggest that solid regulations on wholesalers and a fair pharmaceutical trading environment should be effective strategies to enhancing the transparency of pharmaceutical drug structures.
목차
Abstract I. 서론 II. 연구 방법 1. 연구설계 2. 연구대상 3. 인터뷰 과정 및 진행 III. 결과 1. 의약품 유통 현상 및 특징 2. 의약품 유통 구조의 문제점 3. 의약품 유통 구조 개선 방안 IV. 고찰 및 결론 이해 상충 참고문헌
한국에프디시규제과학회(구 한국에프디시법제학회) [The Korean Society of Food, Drug and Cosmetic Regulatory Sciences]
설립연도
2006
분야
의약학>약학
소개
본회는 의약품, 의약외품, 의료기기, 화장품 및 건강기능식품 등과 관련된 국내·외의 각종 법령과 규정 등에 대한 연구와 발표 등을 통하여 합리적이고 투명한 법령과 규정의 제·개정 및 정책개발에 기여함으로써 관련 산업의 발전과 국민의 건강증진에 기여하며 회원 상호 간의 친목을 도모함을 목적으로 한다.
간행물
간행물명
KFDC규제과학회지(구 FDC법제연구) [Regulatory Research on Food, Drug and Cosmetic]